Who owns Northwest Biotherapeutics In?
- Ticker: NWBO
- CUSIP Number: 66737P600
Tip: Access positions for across all investors
Analyze quarterly positions in Northwest Biotherapeutics In with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Northwest Biotherapeutics In stock
Who bought or sold Northwest Biotherapeutics In this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Compass Financial Management | 1.2M | $227k | 100% | Jun 2026 |
|
| Wall Street Access Asset Management | 800k | $149k | 300% | Jun 2026 |
|
| VSM Wealth Advisory | 81k | $15k | 0% | Jun 2026 |
|
| Opus Capital Group | 60k | $11k | 0% | Jun 2026 |
|
| Ethos Financial Group | 39k | $6.3k | 0% | Jun 2026 |
|
| Williams Jones Wealth Management | 25k | $4.7k | 0% | Jun 2026 |
|
| Coston, McIsaac & Partners | 1.0k | $0 | 0% | Jun 2026 |
|
| McIlrath & Eck | 600.00 | $124.020000 | 100% | Mar 2026 |
|
| Hantz Financial Services | 250.00 | $0 | 0% | Jun 2026 |
|